As various mental disorders, including anxiety (Davis, 1992), depression (Siegle et al., 2007; Shen et al., 2019), and PTSD (Shin et al., 2006), are highly correlated with hyperactivation and dysfunction of the amygdala and the fear memory circuitry, our finding supports CCK and its receptors as potential new targets for future therapeutic applications for these disorders. The gene discussed is CCK; the disease is post-traumatic stress disorder.